Versant Vantage II GP-GP, LLC - Insider Non-Derivative Transactions at LENZ Therapeutics, Inc. (LENZ) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 30, 2025, Versant Vantage II GP-GP, LLC's relationship to LENZ Therapeutics, Inc. (LENZ) is TenPercentOwner, and currently has 1,133,842 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LENZ insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Versant Vantage II GP-GP, LLC - Insider Non-Derivative Transactions of LENZ Common Stock

Versant Vantage II GP-GP, LLC - Insider Non-Derivative Transactions at LENZ

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 1, 2025	Sell -- (Common Stock)	123	47.01	764127
Oct 1, 2025	Sell -- (Common Stock)	57502	46.41	764250
Oct 1, 2025	Sell -- (Common Stock)	34405	45.35	821752
Oct 1, 2025	Sell -- (Common Stock)	177	47.01	1050599
Oct 1, 2025	Sell -- (Common Stock)	83066	46.41	1050776
Oct 1, 2025	Sell -- (Common Stock)	49701	45.35	1133842
Jun 28, 2025	Sell -- (Common Stock)	200000	30.47	1767275
Jun 11, 2025	Sell -- (Common Stock)	350000	29	1248789